RxDoctor Payments Data

Robin Stone, MD

Family Medicine · Hodges, SCNPI 1992799316

Payments from drug & device makers

$10,150in general payments, 2019–2025

Across 675 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$982
  • Lilly USA, LLC$966
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$960
  • AstraZeneca$698
  • Novo Nordisk$651
  • Takeda Pharmaceuticals U.S.A., Inc.$640
  • plus $5K from 43 others

What the payments were for

  • Food & beverage$10,05099%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,150 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$233,261
Medicare patients
441
Services billed
3,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin155$142,816
OzempicSemaglutide117$110,823
MounjaroTirzepatide103$107,688
FarxigaDapagliflozin Propanediol44$48,506
EliquisApixaban36$38,517
TrulicityDulaglutide20$23,821
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$23,087
LinzessLinaclotide19$14,349
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,772
XareltoRivaroxaban17$10,262
Tresiba Flextouch U-200Insulin Degludec17$9,982
GemtesaVibegron13$8,636
Rosuvastatin Calcium436$7,725
MyrbetriqMirabegron11$7,318
Spiriva HandihalerTiotropium Bromide11$6,206

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$558$142,816155 claims
Lilly USA, LLCMounjaro, Trulicity$966$131,509123 claims
Novo NordiskOzempic$651$110,823117 claims
AstraZenecaFarxiga, Breztri Aerosphere$698$71,59375 claims
PfizerEliquis$638$38,51736 claims
AbbVieLinzess, Synthroid$982$18,66692 claims
GSKTrelegy Ellipta, Incruse Ellipta$328$18,30625 claims
Johnson & JohnsonXarelto$11$10,26217 claims
Sumitomo Pharma America, Inc.Gemtesa$54$8,63613 claims
Astellas Pharma US IncMyrbetriq$232$7,31811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Hodges

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →